Diagnostic and surveillance testing capability for mpox in the EU/EEA, September 2024
In response to the increasing number of mpox cases caused by monkeypox virus (MPXV) clade I in the African continent and the first reported travel-related clade Ib case of mpox in EU/EEA, the European Centre for Disease Prevention and Control surveyed national capability for detection and characterisation of MPXV in the EU/EEA. The results showed high level of capability for case confirmation by PCR, alongside molecular typing methods for identification of MPXV clades and/or clade I subclades within the EU/EEA.
Authors
- Jessica Beser
- Céline M Gossner (ORCID: https://orcid.org/0000-0001-9345-5511)
- Nina Lagerqvist
- Daniel Palm (ORCID: https://orcid.org/0000-0002-2354-5498)
- Tamás Bakonyi
Institutions
- European Centre for Disease Prevention and Control (SE)
Publication Details
- Journal
- Eurosurveillance
- Published
- 2024-10-17
- DOI
- https://doi.org/10.2807/1560-7917.es.2024.29.42.2400632
- Citations
- 1
- Primary Topic
- Poxvirus research and outbreaks
- Type
- article
- Field-Weighted Citation Impact
- 0.29
Funders
- European Centre for Disease Prevention and Control